SFDA Discusses Strengthening Implementation of the Drug Track and Trace System (RSD)

The Saudi Food and Drug Authority (SFDA) recently held a high-level meeting with the National Committee of Pharmacies of the Federation of Saudi Chambers to discuss strengthening implementation of the national Drug Track and Trace System (RSD).

The meeting, held on 5 January 2026 at SFDA headquarters in Riyadh, brought together specialists from both sides to review current challenges facing pharmacies in complying with RSD requirements and to explore practical ways to enhance overall implementation efficiency.

The discussions focused on improving drug safety and quality, reinforcing the reliability of the pharmaceutical supply chain, and increasing the efficiency of data exchange related to pharmaceutical tracking to ensure more robust oversight of medicines in the Kingdom.

During the meeting, SFDA and the Committee emphasized the importance of developing the regulatory and technical work environment so that RSD keeps pace with Saudi Arabia’s broader digital transformation goals in the healthcare sector.

SFDA reiterated its commitment to working in an integrated manner with the private sector to address system-wide challenges that have a public impact, supporting the stability of the pharmaceutical market and helping pharmacies remain prepared to meet evolving regulatory requirements.

Both parties stressed the need for ongoing coordination and follow-up to achieve shared objectives, enhance the efficiency of the healthcare system, and strengthen public trust in the national pharmaceutical system by ensuring that the track and trace infrastructure effectively protects public health.

Learn more: SFDA Discusses Enhancing Implementation of Drug Track and Trace System (RSD) with National Committee of Pharmacies